The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Structural Heart Devices Market Over The Period 2026–2030?
The structural heart devices market has shown robust expansion in recent years. It is forecast to grow from $11.37 billion in 2025 to $12.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.8%. This historical growth can be linked to the increasing occurrence of structural heart conditions, the global rise in the elderly population, the prompt adoption of valve replacement technologies, the proliferation of cardiac specialty centers, and enhancements in interventional cardiology methods.
The structural heart devices market is projected to experience substantial expansion over the next few years. It is anticipated to grow to $17.23 billion in 2030, achieving a compound annual growth rate (CAGR) of 8.4%. This expansion during the forecast period is primarily driven by a surging preference for minimally invasive procedures, increasing investments in cardiovascular innovation, the broadening of pediatric cardiac interventions, the expanding adoption of AI-assisted diagnostics, and a heightened demand for durable and long-lasting implants. Significant trends expected during this period include the rising adoption of transcatheter heart valve procedures, a growing demand for minimally invasive cardiac implants, the increasing integration of advanced imaging and navigation systems, the expansion of catheter-based delivery technologies, and a stronger focus on patient-specific device design.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15677&type=smp
Which Economic Or Industry Drivers Are Impacting The Structural Heart Devices Market?
The increasing occurrence of cardiovascular conditions is anticipated to boost the expansion of the structural heart device market in the future. Cardiovascular diseases (CVDs) encompass a range of afflictions impacting the heart and its associated blood vessels, including conditions such as coronary artery disease, heart attacks, and strokes. Instances of cardiovascular diseases, specifically heart disease and stroke, have shown a consistent global rise, attributed to inactive lifestyles, unhealthy eating patterns, escalating obesity figures, tobacco use, and an aging demographic. Structural heart devices address cardiovascular ailments by mending or substituting impaired heart valves, rectifying structural flaws, and enhancing cardiac performance and patient prognosis. As an illustration, in January 2024, data from the American Heart Association, a US-based non-profit organization, indicated that the age-adjusted mortality rate from cardiovascular disease climbed to 233.3 per 100,000 in 2024, representing a 4.0% increase from 224.4 per 100,000 in 2023. Consequently, the growing occurrence of cardiovascular diseases is fueling the expansion of the structural heart device market.
How Is The Structural Heart Devices Market Divided Into Its Major Segments?
The structural heart devices market covered in this report is segmented –
1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems
2) By Procedure: Replacement Procedures, Repair Procedures
3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications
4) By Age Group: Pediatric, Adults
Subsegments:
1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings
2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings
3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders
4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems
How Are Trends Transforming The Structural Heart Devices Market Landscape?
Leading companies within the structural heart devices market are concentrating on developing advanced solutions, including innovative next-generation transcatheter heart valves, with the goal of improving durability, decreasing complications, and expanding minimally invasive treatment options. Next-generation transcatheter heart valves are replacement valves that are minimally invasive, featuring advanced materials and attributes like anti-calcification tissue and enhanced sealing, which serve to boost durability and reduce complications when compared to older valves. For instance, in September 2025, Edwards Lifesciences Corporation, a US-based medical technology company, launched a next-generation transcatheter heart valve platform in India, which provides a durable, minimally invasive treatment for aortic stenosis in patients who cannot undergo open-heart surgery. Key attributes of this advanced valve include calcification-resistant tissue technology designed to prevent calcium accumulation and extend longevity, a taller outer sealing skirt to minimize paravalvular leaks, and dry tissue storage to facilitate easier hospital handling. Additionally, the platform supports a “lifetime management” strategy, allowing for minimally invasive valve-in-valve procedures for future interventions and ensuring sustained treatment effectiveness.
Who Are The Prominent Organizations Shaping The Structural Heart Devices Market?
Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH
Read the full structural heart devices market report here:
https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report
What Are The Top-Performing Regions Within The Structural Heart Devices Market?
North America was the largest region in the structural heart devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Structural Heart Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15677&type=smp
Browse Through More Reports Similar to the Global Structural Heart Devices Market 2026, By The Business Research Company
Structural Heart Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report
Cardiac Mapping Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiac-mapping-global-market-report
Cardiovascular Ultrasound Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiovascular-ultrasound-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model